rheumatology
PMR Diagnostic Score (EULAR/ACR 2012)
Classifies polymyalgia rheumatica (PMR) using EULAR/ACR 2012 provisional classification criteria. Score >=4 (without US) or >=5 (with US) = PMR.
Score interpretation
PMR unlikely (<4 points)
→ Criteria not met; consider alternative diagnosis (seronegative RA, inflammatory OA, malignancy)
Possible PMR (4-5 points)
→ Possible PMR; steroid trial (prednisolone 15-20mg/day); USS if uncertain; consider GCA symptoms
Probable PMR (>=6 points)
→ Likely PMR; prednisolone 15-25mg/day; monitor ESR/CRP; watch for giant cell arteritis (visual symptoms, jaw claudication)
Interpretation bands for the PMR Score. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Prednisolone (Systemic) · Systemic Corticosteroid — Acute Dermatoses
- Prednisolone (Systemic) · Systemic Corticosteroid
- Prednisolone · Glucocorticoid (intermediate-acting)
- Prednisolone (Sudden Sensorineural Hearing Loss) · Corticosteroid (systemic — SSNHL treatment)
- Sodium Cromoglicate Nasal Spray · Mast Cell Stabiliser — Allergic Rhinitis
- Prednisolone (Oral — Nasal Polyp Reduction) · Systemic Corticosteroid
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.